Monarch Partners Asset Management LLC Krystal Biotech, Inc. Transaction History
Monarch Partners Asset Management LLC
- $328 Million
- Q4 2022
A detailed history of Monarch Partners Asset Management LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Monarch Partners Asset Management LLC holds 53,905 shares of KRYS stock, worth $9.45 Million. This represents 1.3% of its overall portfolio holdings.
Number of Shares
53,905
Previous 46,494
15.94%
Holding current value
$9.45 Million
Previous $3.24 Million
31.75%
% of portfolio
1.3%
Previous 0.97%
Shares
3 transactions
Others Institutions Holding KRYS
# of Institutions
300Shares Held
24.3MCall Options Held
388KPut Options Held
233K-
Black Rock Inc. New York, NY3.95MShares$692 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.88MShares$504 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.63MShares$461 Million6.0% of portfolio
-
State Street Corp Boston, MA1.28MShares$224 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA879KShares$154 Million0.02% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4.5B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...